Get the Stockscreener App
18.13
0.28%
-0.05
After Hours:
18.13
Innoviva Inc stock is traded at $18.13, with a volume of 633.82K.
It is down -0.28% in the last 24 hours and up +1.17% over the past month.
See More
Previous Close:
$18.18
Open:
$18.18
24h Volume:
633.82K
Relative Volume:
0.89
Market Cap:
$1.12B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
10.99
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
+4.62%
1M Performance:
+1.17%
6M Performance:
-6.11%
1Y Performance:
+18.96%
1-Day Range:
$17.89
$18.27
1-Week Range:
$17.25
$18.34
52-Week Range:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.13 | 1.12B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Raised by HighTower Advisors LLC - Defense World
Can Mixed Fundamentals Have A Negative Impact on Innoviva, Inc. (NASDAQ:INVA) Current Share Price Momentum? - Simply Wall St
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - MSN
Avantax Advisory Services Inc. Grows Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Upgraded to “Buy” at StockNews.com - Defense World
Charles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Sarissa Capital Management LP Reduces Stake in Innoviva Inc. - GuruFocus.com
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by PNC Financial Services Group Inc. - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc. - Defense World
Innoviva (NASDAQ:INVA) Downgraded by StockNews.com to Hold - Defense World
Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - Longview News-Journal
Armata Lands Critical $10M Funding to Push Revolutionary Phage Therapy Toward FDA Meeting - Stock Titan
(INVA) Investment Analysis and Advice - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Research Coverage Started at Scotiabank - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in Stock - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $20,966,989.92 in Stock - Defense World
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - Nasdaq
Innoviva stock sees $28 million sale by Alexander J. Denner - Investing.com Australia
Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - BioSpace
Innoviva CEO Fireside Chat: What Strategic Updates Await at Barclays Healthcare Conference? - Stock Titan
Principal Financial Group Inc. Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Has $3.25 Million Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lowered by Denali Advisors LLC - MarketBeat
When the Price of (INVA) Talks, People Listen - news.stocktradersdaily.com
Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results - MarketBeat
Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat
Innoviva (INVA) to Release Earnings on Thursday - Defense World
Innoviva: Q4 Earnings Snapshot - Thehour.com
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - MarketScreener
Hussman Strategic Advisors Inc. Increases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva: Underappreciated Strength In Hospital Therapeutics (NASDAQ:INVA) - Seeking Alpha
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Innoviva, Inc. (NASDAQ:INVA) Short Interest Update - MarketBeat
Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World
Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
(INVA) Investment Analysis - Stock Traders Daily
Empowered Funds LLC Acquires 4,895 Shares of Innoviva, Inc. (NASDAQ:INVA) - Armenian Reporter
Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World
Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq
Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):